Clinical Trials For frontotemporal dementia To Start By 2013

.

Clinical Trials For frontotemporal dementia To Start By 2013

A neurodegenerative disease, frontotemporal dementia starts with silence and damages personality traits and then affects the brain. It gets very late for doctors to address the problem and till the time they get to know about, a person suffering from it, is left with very less time.

The disease was first discovered some 100 years back, but then also researchers have not been able to find probable reasons as well as treatment of the problem. It has also been found those maximum survival years of person after diagnosis of disease is not more than eight years.

However, researchers at the University of California have identified drugs that can treat the rare neurodegenerative problem. It is said that the study researchers are going to initiate clinical trials for the same by 2013.

Dr. Bruce L. Miller, who is a Professor of neurology and psychiatry in University of California, said that it is high time that researchers should know that there are different subtypes of dementia. "I think at least some subtypes of frontotemporal dementia will be the first neurodegenerative diseases we find a cure for", said Miller.

Miller further said that there are chances that the development helps understanding Alzheimer's disease in a better way.


Latest News

Brazilian President Says Growth in the U.S. Could Result in an Improvement of Br
Anonymous Whistleblower to get $30 Million from SEC
Siemens Plans to Acquire Dresser-Rand for $6 billion Says Sources
OSI Group to Cut 340 Jobs in China in Relation to Food Safety Scandal
PARK(ing) Day Celebration Turns Parking Spots into Temporary Parks
Oasis Beverages a Russian Company Buys Pabst
About 6.4 trillion calories to be cut from food products
Rise in sexually transmitted infections worry all
Breast cancer awareness taken to another level by foundation
Practicing yoga can help bipolar disorder
Oracle’s Chief Larry Ellison Retires
Price of Alibaba IPO Remains at Top Range